Top News

FEATURED

Air Pollution, Lung Cancer Survival

An analysis of over 20 years of health data indicates that exposure to air pollution is correlated with worsened survival outcomes for patients diagnosed with lung cancer.

Relationship Between Mutant KRAS and ACLS3

Research has uncovered a potential treatment target for mutant KRAS non-small cell lung cancer: Acyl-Coenzyme A synthetase long chain family member 3.

Breast Cancer: Insights from the Lab

Chapter 1: Drs. O’Shaughnessy and Rugo discuss recent treatment advances for patients with HER2+ metastatic breast cancer.

Partnership Harnesses Mobile Technology

MSKCC is teaming up with Medidata to test the use of wearable activity trackers among patients with multiple myeloma undergoing treatment for their disease.

Melanoma: New Mechanism of Treatment Resistance

Researchers were able to increase sensitivity to vemurafinib in resistant melanoma cell lines by reactivating genes that are involved in cell division.

Poor Sleep Quality, Symptom Burden

Patients who slept poorly exhibited greater symptom burden and overall mood disturbance.

Endocrine Therapy Continuation Beyond 5 Years?

Using case studies, experts discuss the Breast Cancer Index<sup>SM</sup> as a tool for clinicians and patients considering extended adjuvant endocrine therapy for early-stage ER+ breast cancer.

New Video Series: High-Risk Hodgkin Lymphoma

Patrick J. Stiff, MD of the Cardinal Bernardin Cancer Center in Maywood, Illinois

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Latest Features

Air Pollution May Affect Survival of Lung Cancer

Air Pollution May Affect Survival of Lung Cancer

An analysis of over 20 years of health data indicates that exposure to air pollution is correlated with worsened survival outcomes for patients diagnosed with lung cancer.

Relationship Between Mutant KRAS and ACLS3 Opens Door to Therapy Development for NSCLC

Relationship Between Mutant KRAS and ACLS3 Opens Door to Therapy Development for NSCLC

Research has uncovered a potential treatment target for mutant KRAS non-small cell lung cancer: Acyl-Coenzyme A synthetase long chain family member 3.

Medidata Partnership With MSKCC Harnesses Mobile Technology to Track Quality of Life With Myeloma

Medidata Partnership With MSKCC Harnesses Mobile Technology to Track Quality of Life With Myeloma

MSKCC is teaming up with Medidata to test the use of wearable activity trackers among patients with multiple myeloma undergoing treatment for their disease.

New Mechanism of Treatment Resistance in BRAF-Mutant Melanoma Identified

New Mechanism of Treatment Resistance in BRAF-Mutant Melanoma Identified

Researchers were able to increase sensitivity to vemurafinib in resistant melanoma cell lines by reactivating genes that are involved in cell division.

Poor Sleep Quality Associated With Symptom Burden Among Phase 1 Trial Participants

Poor Sleep Quality Associated With Symptom Burden Among Phase 1 Trial Participants

Patients who slept poorly exhibited greater symptom burden and overall mood disturbance.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters